SPAC1782.12c Antibody

What is SPAC1782.12c and why is it significant for research?

SPAC1782.12c is a UPF0382 family membrane protein found in Schizosaccharomyces pombe (fission yeast) with UniProt ID Q9P7G8 . It is a relatively small protein comprising 100 amino acids (positions 19-118 of the mature protein) with a molecular structure that features several transmembrane domains . The significance of this protein lies in understanding membrane protein organization and function in S. pombe, which serves as a model organism for studying eukaryotic cellular processes. Research on this protein contributes to our fundamental understanding of membrane protein biology and potentially conserved functions across species.

What are the optimal storage conditions for SPAC1782.12c antibodies?

SPAC1782.12c antibodies should be stored at -20°C to -80°C for long-term preservation . For short-term use (up to one week), working aliquots can be maintained at 4°C . To prevent protein degradation and loss of binding activity, repeated freeze-thaw cycles must be avoided. For reconstituted antibodies, adding glycerol to a final concentration of 5-50% (with 50% being optimal) creates a stabilizing environment for long-term storage . Always centrifuge vials briefly before opening to ensure the antibody solution is at the bottom of the container, particularly after thawing.

What expression systems are most effective for generating recombinant SPAC1782.12c protein for antibody production?

E. coli expression systems have proven effective for the production of recombinant SPAC1782.12c protein, particularly when the protein is fused to an N-terminal His tag for purification purposes . This approach generates protein with greater than 90% purity as determined by SDS-PAGE analysis . For optimal results, the recombinant protein should include amino acids 19-118 of the mature protein sequence, which encompasses the functional domains while excluding regions that might interfere with proper folding. Alternative expression systems such as yeast or insect cells might be considered for more complex applications requiring post-translational modifications, though these are not documented in the current literature for this specific protein.

How should SPAC1782.12c antibodies be validated for specificity?

Validation of SPAC1782.12c antibodies should employ multiple complementary approaches:

• Western blot analysis with recombinant SPAC1782.12c protein as a positive control

• Immunoprecipitation followed by mass spectrometry identification

• Immunofluorescence microscopy in S. pombe cells with appropriate controls

• Knockout/knockdown studies comparing antibody signals in wild-type versus SPAC1782.12c-depleted cells

• Cross-reactivity testing against homologous proteins in related species

Proper validation requires demonstrating specific binding to the target protein while showing minimal cross-reactivity with other cellular proteins. For membrane proteins like SPAC1782.12c, particular attention should be paid to extraction methods that preserve epitope accessibility while maintaining protein folding.

How can researchers overcome challenges associated with the membrane-bound nature of SPAC1782.12c for antibody applications?

The membrane-bound nature of SPAC1782.12c presents several challenges for antibody applications that can be addressed through these methodological approaches:

• Protein Extraction Optimization: Use mild detergents (e.g., n-dodecyl-β-D-maltoside or digitonin) that maintain protein structure while solubilizing membrane components. A step-wise detergent screening approach helps identify optimal conditions.

• Native Conformation Preservation: When producing antibodies, consider using synthetic peptides corresponding to extracellular domains or recombinant protein fragments that maintain natural folding rather than denatured full-length protein.

• Proximity Labeling Approaches: For interaction studies, techniques like BioID or APEX2 can be used to identify proteins in close proximity to SPAC1782.12c without requiring direct antibody access to the membrane-embedded protein.

• Live-Cell Imaging Adaptations: For imaging applications, consider a split-GFP approach where one fragment is fused to an accessible region of SPAC1782.12c, enabling visualization without requiring antibody penetration of the membrane.

• Fixation Protocol Optimization: Systematic testing of different fixation and permeabilization conditions can significantly improve epitope accessibility while preserving cellular morphology.

These strategies help address the inherent difficulties of working with membrane proteins while maximizing antibody specificity and sensitivity in various experimental contexts.

What are the recommended approaches for using SPAC1782.12c antibodies in co-immunoprecipitation studies?

Co-immunoprecipitation (co-IP) studies with SPAC1782.12c antibodies require careful optimization due to the protein's membrane localization:

• Membrane Solubilization Strategy:

  • Begin with a detergent panel test (CHAPS, digitonin, NP-40, Triton X-100)

  • Optimize detergent concentration to maintain protein-protein interactions

  • Consider crosslinking before lysis (formaldehyde or DSP) to stabilize transient interactions

• Antibody Coupling Method:

  • Direct coupling to magnetic beads using NHS-ester chemistry

  • Pre-clearing lysates with unconjugated beads to reduce non-specific binding

  • Using oriented coupling strategies to maximize antibody binding capacity

• Experimental Controls:

  • Include isotype-matched control antibodies

  • Perform parallel IPs in knockout/knockdown cells

  • Validate interactions with reciprocal co-IPs when possible

• Detection Strategy:

  • Silver staining followed by mass spectrometry for unbiased interaction discovery

  • Western blotting for verification of specific interaction partners

  • Adjusting salt concentration in wash buffers to optimize stringency

For quantitative co-IP studies, consider SILAC or TMT labeling approaches to distinguish specific interactors from background proteins, particularly important for membrane proteins that tend to have higher non-specific binding profiles.

How can researchers interpret contradictory results when using different SPAC1782.12c antibodies?

Contradictory results between different SPAC1782.12c antibodies can arise from several factors that require systematic investigation:

• Epitope Mapping Analysis:

  • Determine the specific epitopes recognized by each antibody

  • Assess whether post-translational modifications might affect epitope accessibility

  • Consider that different antibodies may recognize different conformational states

• Isoform-Specific Recognition:

  • Verify whether contradictory results stem from differential recognition of splice variants or processed forms

  • Validate antibody recognition patterns using recombinant protein controls

• Methodological Approach to Resolution:

  • Perform side-by-side comparison under identical experimental conditions

  • Validate each antibody using orthogonal techniques (e.g., mass spectrometry)

  • Consider using CRISPR-tagged endogenous protein as a definitive control

• Technical Considerations:

  • Evaluate batch-to-batch variation in antibody production

  • Assess the impact of different fixation or extraction methods on epitope availability

  • Determine antibody sensitivity thresholds that might explain discrepancies

When reporting contradictory results, researchers should provide comprehensive documentation of the specific antibodies used (including catalog numbers and lot numbers), detailed methodological protocols, and appropriate controls to facilitate interpretation and reproducibility.

What are the recommended protocols for using SPAC1782.12c antibodies in immunofluorescence microscopy?

For optimal immunofluorescence microscopy using SPAC1782.12c antibodies, the following protocol elements are critical:

• Cell Preparation:

  • Culture S. pombe cells to mid-log phase (OD600 0.5-0.8)

  • Perform cell wall digestion with zymolyase (100T, 1mg/ml) for 20-30 minutes

  • Fix with 4% paraformaldehyde for 15 minutes at room temperature

• Permeabilization Optimization:

  • Test multiple permeabilization agents (0.1% Triton X-100, 0.1% saponin, or 0.05% SDS)

  • For membrane proteins like SPAC1782.12c, gentle permeabilization with saponin often preserves epitope accessibility while maintaining membrane structure

• Antibody Incubation Parameters:

  • Dilute primary antibody in blocking buffer (1% BSA, 0.1% saponin in PBS)

  • Incubate overnight at 4°C in a humidified chamber

  • Use fluorophore-conjugated secondary antibodies with minimal cross-reactivity

• Critical Controls:

  • SPAC1782.12c knockout/knockdown cells as negative controls

  • Co-localization with known membrane markers (e.g., ER, Golgi, plasma membrane)

  • Pre-absorption controls to confirm antibody specificity

• Image Acquisition Parameters:

  • Capture z-stacks to fully visualize membrane distributions

  • Use deconvolution algorithms to improve signal-to-noise ratio

  • Employ quantitative analysis of signal intensity and co-localization

For super-resolution microscopy applications, additional optimization of fixation methods and antibody concentration is necessary to achieve sufficient labeling density while maintaining specificity.

How can researchers develop quantitative assays using SPAC1782.12c antibodies?

Developing robust quantitative assays with SPAC1782.12c antibodies requires careful consideration of assay design principles:

• ELISA Development Strategy:

  • Sandwich ELISA using capture and detection antibodies recognizing different epitopes

  • Direct ELISA with recombinant protein standards for calibration

  • Competitive ELISA for measuring native protein in complex samples

• Standard Curve Optimization:

  • Use purified recombinant SPAC1782.12c protein at concentrations ranging from 0.1-100 ng/ml

  • Prepare standards in the same matrix as experimental samples

  • Validate linearity across the expected concentration range

• Sample Preparation Considerations:

  • Standardize detergent-based extraction methods

  • Normalize protein concentration across samples

  • Address potential interfering substances through dilution or pre-clearing steps

• Assay Validation Parameters:

  • Establish lower and upper limits of quantification

  • Determine intra-assay and inter-assay variation coefficients

  • Validate recovery using spike-in experiments

• Alternative Quantitative Approaches:

  • Flow cytometry for single-cell quantification

  • Capillary electrophoresis immunoassay for higher sensitivity

  • Mass spectrometry with isotope-labeled peptide standards for absolute quantification

When developing multiplexed assays that include SPAC1782.12c, carefully assess antibody cross-reactivity and optimize signal-to-noise ratios for each target to ensure accurate quantification in complex samples.

What controls are essential when using SPAC1782.12c antibodies in chromatin immunoprecipitation (ChIP) experiments?

While SPAC1782.12c is primarily characterized as a membrane protein rather than a DNA-binding factor, researchers occasionally investigate potential chromatin associations of membrane proteins. If conducting ChIP experiments with SPAC1782.12c antibodies, these essential controls should be implemented:

• Negative Controls:

  • SPAC1782.12c knockout/knockdown cells

  • Non-specific IgG matching the host species of the primary antibody

  • Non-crosslinked samples to identify potential direct DNA binding

• Positive Controls:

  • ChIP with antibodies against known DNA-binding proteins

  • Input DNA samples at multiple dilutions

  • Spike-in of exogenous chromatin for normalization

• Technical Validation:

  • Independent biological replicates to establish reproducibility

  • Sequential ChIP (re-ChIP) to verify co-occupancy with interacting partners

  • Alternative crosslinking methods to capture different types of interactions

• Data Analysis Considerations:

  • Multiple normalization strategies (input, spike-in, housekeeping loci)

  • Statistical analysis of enrichment over background

  • Correlation analysis between replicates to assess consistency

Given the unusual nature of investigating a membrane protein in ChIP experiments, researchers should provide strong justification for the biological hypothesis and include additional controls to rule out potential artifacts from membrane contamination or indirect associations.

How can researchers optimize western blot protocols for detecting SPAC1782.12c?

Optimizing western blot protocols for membrane proteins like SPAC1782.12c requires attention to several critical parameters:

• Sample Preparation:

  • Extract with buffer containing 1% SDS or 1% Triton X-100

  • Include protease inhibitors to prevent degradation

  • Avoid boiling samples (heat to 37°C for 30 minutes instead)

  • Add reducing agents (DTT or β-mercaptoethanol) to break disulfide bonds

• Gel Electrophoresis Conditions:

  • Use gradient gels (4-15% or 4-20%) for better resolution

  • Consider specialized gel systems for membrane proteins (Tricine-SDS-PAGE)

  • Load 20-50 μg total protein per lane for adequate detection

• Transfer Optimization:

  • Use PVDF membranes (0.2 μm pore size) for better protein retention

  • Add 0.1% SDS to transfer buffer to improve elution from gel

  • Extend transfer time (overnight at low voltage) for efficient transfer

  • Validate transfer efficiency with reversible protein stains

• Blocking and Antibody Incubation:

  • Block with 5% non-fat dry milk or 3% BSA in TBST

  • Optimize primary antibody dilution (typically 1:500 to 1:2000)

  • Extend primary antibody incubation to overnight at 4°C

  • Use enhanced chemiluminescence detection systems for improved sensitivity

• Expected Results:

  • SPAC1782.12c should appear at approximately 12-14 kDa

  • Membrane proteins may show anomalous migration patterns

  • Potential detection of dimers or oligomers if sample preparation disrupts native structure

If aggregation occurs during sample preparation, consider alternative detergents like n-dodecyl-β-D-maltoside or CHAPS, which are milder and may better preserve protein structure while effectively solubilizing membrane components.

What approaches can be used to enhance signal-to-noise ratio when working with SPAC1782.12c antibodies?

Enhancing signal-to-noise ratio for SPAC1782.12c antibody applications involves multiple strategic approaches:

• Antibody Purification Methods:

  • Affinity purification against recombinant SPAC1782.12c

  • Negative selection against lysates from knockout cells

  • Isotype-specific purification to remove contaminating antibodies

• Signal Amplification Strategies:

  • Tyramide signal amplification for immunohistochemistry

  • Poly-HRP secondary antibodies for western blotting

  • Quantum dot conjugates for fluorescence applications

• Background Reduction Techniques:

  • Extensive pre-clearing of samples with protein A/G beads

  • Including competitors for common non-specific interactions (e.g., BSA, non-immune serum)

  • Using detergent optimized wash buffers with titrated salt concentration

• Advanced Detection Systems:

  • Automated western blot processors for consistent washing

  • Fluorescence-based detection to expand dynamic range

  • Digital image acquisition with background correction algorithms

• Sample Pre-treatment:

  • Immunodepletion of abundant proteins that contribute to background

  • Subcellular fractionation to enrich for membrane components

  • Size exclusion chromatography to separate protein complexes

When combining multiple approaches, validate that signal enhancement methods do not introduce artifacts by comparing results with unenhanced protocols using well-characterized positive and negative controls.

What are the recommended approaches for generating and validating custom SPAC1782.12c antibodies?

For researchers developing custom antibodies against SPAC1782.12c, the following comprehensive approach is recommended:

• Antigen Design Strategy:

  • Select multiple epitopes (12-20 amino acids) from hydrophilic regions

  • Consider KLH or BSA conjugation for small peptides

  • Use recombinant protein fragments excluding transmembrane domains

  • Potential epitope regions based on amino acid sequence:

    • N-terminal region: AYGSHGLQKRVQDPH (amino acids 19-33)

    • Predicted loop region: PYGKSRWTGPL (amino acids 59-69)

• Immunization Protocol:

  • Use multiple animal hosts (rabbit, guinea pig, chicken) for diverse antibody properties

  • Implement long-term immunization schedule (12-16 weeks)

  • Collect pre-immune sera as critical negative controls

  • Monitor antibody titers using ELISA before final collection

• Purification Strategy:

  • Initial purification using protein A/G for IgG isolation

  • Subsequent affinity purification against the immunizing antigen

  • Negative selection against related proteins to remove cross-reactivity

  • Quality control by SDS-PAGE to verify purity

• Validation Requirements:

  Validation Method	Acceptance Criteria	Control Samples
  Western blot	Single band at expected MW	Knockout/knockdown cells
  Immunoprecipitation	Enrichment >10-fold	IgG control
  Peptide competition	>80% signal reduction	Irrelevant peptide
  Mass spectrometry	Protein identification	Pre-immune serum IP
  Immunofluorescence	Correct subcellular pattern	Secondary antibody alone

• Documentation Standards:

  • Complete record of immunogen sequence and design

  • Detailed immunization protocol and antibody production methods

  • Comprehensive validation data across multiple applications

  • Lot-to-lot consistency assessment for polyclonal antibodies

For monoclonal antibody development, additional screening steps should be implemented to identify clones that recognize native protein conformations and function effectively across multiple applications.

How should researchers approach epitope mapping for SPAC1782.12c antibodies?

Comprehensive epitope mapping for SPAC1782.12c antibodies can be approached through multiple complementary methods:

• Peptide Array Analysis:

  • Generate overlapping peptides (12-15 amino acids) covering the entire SPAC1782.12c sequence

  • Synthesize peptides with 3-5 amino acid offsets to ensure comprehensive coverage

  • Spot peptides onto membranes and probe with antibody

  • Identify reactive peptides to define the linear epitope boundaries

• Deletion Mutant Strategy:

  • Create N-terminal and C-terminal truncation series of SPAC1782.12c

  • Express recombinant fragments as fusion proteins

  • Test antibody reactivity against each fragment

  • Narrow down the reactive region through systematic deletion analysis

• Alanine Scanning Mutagenesis:

  • Once the epitope region is identified, create point mutations replacing each residue with alanine

  • Test antibody binding to each mutant

  • Identify critical residues required for antibody recognition

  • Generate 3D models of the epitope-antibody interaction

• Hydrogen-Deuterium Exchange Mass Spectrometry:

  • Compare deuterium uptake patterns of SPAC1782.12c in the presence and absence of antibody

  • Identify regions with reduced exchange rates indicating antibody binding

  • Particularly valuable for conformational epitopes not detected by linear peptide mapping

• X-ray Crystallography or Cryo-EM:

  • For highest resolution epitope definition, determine the structure of the antibody-antigen complex

  • Identify specific atomic interactions at the binding interface

  • Particularly important for antibodies used in structural biology applications

The comprehensive epitope mapping data should be used to predict potential cross-reactivity with related proteins, assess epitope conservation across species, and inform antibody application optimization for specific experimental contexts.

How can SPAC1782.12c antibodies be used to investigate protein-protein interactions in membrane complexes?

SPAC1782.12c antibodies offer valuable tools for investigating membrane protein interactions through these methodological approaches:

• Proximity-Based Interaction Discovery:

  • BioID fusion with SPAC1782.12c to identify proximal proteins

  • APEX2-based proximity labeling in living cells

  • Antibody-based validation of identified interaction partners

• Co-Immunoprecipitation Strategies:

  • Antibody-based pulldown from membrane fractions

  • Chemical crosslinking prior to solubilization to capture transient interactions

  • Two-step purification using epitope-tagged constructs and antibodies

• Fluorescence-Based Interaction Analysis:

  • Förster Resonance Energy Transfer (FRET) between labeled antibodies

  • Fluorescence complementation assays with split fluorescent proteins

  • Super-resolution co-localization studies using dual-labeled antibodies

• Mass Spectrometry Integration:

  • Antibody-based purification coupled with quantitative proteomics

  • SILAC or TMT labeling to distinguish specific interactors from background

  • Peptide-specific fragmentation methods for enhanced membrane protein identification

• Functional Validation Approaches:

  • Antibody inhibition of protein-protein interactions

  • Competition assays with recombinant protein domains

  • Mutational analysis guided by interaction mapping

These methodologies collectively enable researchers to build comprehensive interaction networks centered on SPAC1782.12c, providing insights into its functional role within membrane-associated complexes in S. pombe.

What are the emerging applications of SPAC1782.12c antibodies in structural biology research?

SPAC1782.12c antibodies are increasingly valuable tools in structural biology, offering several innovative applications:

• Antibody-Mediated Crystallization:

  • Fab fragments as crystallization chaperones for membrane proteins

  • Co-crystallization to stabilize flexible regions of SPAC1782.12c

  • Structure determination of protein-antibody complexes to infer native conformations

• Single-Particle Cryo-EM Applications:

  • Antibody labeling to increase particle size for improved alignment

  • Identification of specific domains in large complexes

  • Conformational selection through antibody binding

• Integrative Structural Biology Approaches:

  • Antibody-based distance measurements through FRET or EPR

  • Validation of computational models through epitope accessibility

  • Cross-linking mass spectrometry with antibody-defined constraints

• Dynamic Structural Analysis:

  • Antibodies as probes for conformational changes

  • Time-resolved structural studies using antibody binding kinetics

  • Identification of functionally relevant structural intermediates

• Methodological Innovations:

  • Nanobody development for improved penetration in structural studies

  • Antibody-directed local labeling for targeted structural analysis

  • Integration with hydrogen-deuterium exchange mass spectrometry

These emerging applications demonstrate how SPAC1782.12c antibodies contribute not only to functional characterization but also to fundamental understanding of membrane protein structure and dynamics.

How can researchers address challenges in reproducing antibody-based experiments with SPAC1782.12c?

Addressing reproducibility challenges in SPAC1782.12c antibody-based research requires systematic implementation of these best practices:

• Comprehensive Antibody Documentation:

  • Record complete antibody metadata (source, catalog number, lot number, validation data)

  • Document exact dilutions, incubation conditions, and buffer compositions

  • Maintain detailed protocols with timing of each experimental step

• Validation Across Experimental Contexts:

  • Verify antibody performance in each specific application

  • Include appropriate positive and negative controls in every experiment

  • Perform epitope competition assays to confirm specificity in new experimental settings

• Multiple Antibody Approach:

  • Use at least two independent antibodies targeting different epitopes

  • Compare results between polyclonal and monoclonal antibodies

  • Consider orthogonal approaches that don't rely on antibodies

• Standardization Strategies:

  • Develop shared reference standards for antibody validation

  • Implement quantitative metrics for antibody performance

  • Create detailed standard operating procedures for each application

• Open Science Practices:

  • Share raw data and complete methodological details

  • Deposit validation data in public repositories

  • Engage with community standardization efforts

When reproducibility issues arise, systematic troubleshooting should include side-by-side comparisons of protocols, reagents, and environmental conditions, with careful documentation of all variables that might influence experimental outcomes.

What future directions are anticipated for SPAC1782.12c antibody development and applications?

The field of SPAC1782.12c antibody research is poised for several exciting developments in coming years:

• Next-Generation Antibody Formats:

  • Single-domain antibodies with enhanced membrane penetration

  • Bispecific antibodies targeting SPAC1782.12c and interacting partners

  • Intrabodies designed for in vivo imaging and manipulation

• Integration with Emerging Technologies:

  • CRISPR-based endogenous tagging for antibody-free detection

  • Expansion microscopy for improved spatial resolution of membrane structures

  • Advanced microfluidic platforms for high-throughput antibody screening

• Systems Biology Applications:

  • Multi-parameter antibody arrays for membrane proteome profiling

  • Integration with lipidomics to study protein-lipid interactions

  • Computational models incorporating antibody-derived structural constraints

• Translational Research Potential:

  • Comparative studies of homologous proteins across species

  • Investigation of related membrane proteins in human cells

  • Exploration of potential functional conservation in health and disease

• Methodological Innovations:

  • DNA-encoded antibody libraries for high-throughput screening

  • Photoswitchable antibodies for super-resolution imaging

  • Antibody engineering for enhanced specificity and reduced background

These future directions highlight how continued development of SPAC1782.12c antibodies will contribute not only to our understanding of this specific protein but also to broader advances in membrane protein research methodologies and applications.